Department of Cariology, Restorative Sciences, and Endodontics, University of Michigan School of Dentistry, Ann Arbor, Michigan; Graduate Program in Dentistry, School of Dentistry, Federal University of Pelotas, Pelotas, Rio Grande do Sul, Brazil.
Department of Conservative Dentistry, School of Dentistry, Federal University of Rio Grande do Sul, Porto Alegre, Rio Grande do Sul, Brazil.
J Endod. 2020 Sep;46(9S):S115-S127. doi: 10.1016/j.joen.2020.06.032.
This review aimed to provide a critical appraisal of alternative antimicrobial strategies in lieu of traditional triple antibiotic paste (TAP).
This review followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement. The literature search was performed in 8 databases (PubMed/Medline, Embase, LILACS, Web of Science, Scopus, BVS, SciELO, and the Cochrane Library), selecting clinical, in vitro, in vivo, and in situ studies that evaluated antimicrobial alternatives to TAP in regenerative endodontics. Studies lacking an experimental TAP group were excluded.
A total of 1705 potentially relevant records were initially identified. From the 38 studies retrieved for full-text reading, 16 fulfilled all selection criteria and were included in the qualitative analysis. According to the study design, 11 studies were solely in vitro, 1 study was both in vitro and in vivo (animal model), 2 studies were solely animal experiments, and 2 studies were clinical trials. The alternative antimicrobial agents to TAP consisted of modified TAP formulations (eg, a combination of TAP with chitosan); TAP-eluting nanofibers; propolis; chlorhexidine (CHX) gels/solutions; double antibiotic pastes composed of distinct combinations of antibiotics; Ca(OH)-based formulations; and sodium hypochlorite. Overall, most of the alternative agents performed similarly to TAP, although some strategies (eg, Ca(OH)- and CHX-based formulations) seemed to present dubious importance in the control of infection.
TAP still remains an excellent option in terms of the complete elimination of microorganisms. This review points to the use of electrospun fibers as a drug delivery system to offer a controlled release of the antimicrobial agent, as well as the use of natural compounds, deserving future investigation.
本综述旨在评估替代传统三联抗生素糊剂(TAP)的抗菌策略。
本综述遵循系统评价和荟萃分析的首选报告项目(PRISMA)声明。文献检索在 8 个数据库(PubMed/Medline、Embase、LILACS、Web of Science、Scopus、BVS、SciELO 和 Cochrane 图书馆)中进行,选择评估再生牙髓治疗中 TAP 替代抗菌剂的临床、体外、体内和原位研究。排除缺乏实验性 TAP 组的研究。
最初共确定了 1705 篇潜在相关记录。从检索到的 38 篇全文阅读研究中,有 16 篇符合所有入选标准,并纳入定性分析。根据研究设计,11 项研究为单纯体外研究,1 项研究为体外和体内(动物模型)研究,2 项研究为单纯动物实验,2 项研究为临床试验。替代 TAP 的抗菌剂包括改良 TAP 制剂(如 TAP 与壳聚糖的组合);TAP 洗脱纳米纤维;蜂胶;洗必泰(CHX)凝胶/溶液;由不同抗生素组合组成的双抗生素糊剂;基于 Ca(OH)的制剂;和次氯酸钠。总体而言,大多数替代剂与 TAP 表现相似,尽管一些策略(如基于 Ca(OH)和 CHX 的制剂)在控制感染方面似乎存在问题。
就完全消除微生物而言,TAP 仍然是一个极好的选择。本综述指出,使用电纺纤维作为药物输送系统可以提供抗菌剂的控制释放,以及使用天然化合物,值得进一步研究。